Orders placed by 14:00 on a business day leave Poland the same day. Free shipping from €100
Product question?Write to us
RUO

All products are chemical reagents for scientific research only. Not for consumption or use in humans or animals. Policy

Quality control

Reference: where impurities in a synthetic peptide come from

11 November 2026 · 5 min read

When a certificate reports 98 percent purity, the obvious question is what the other 2 percent is. For a synthetic peptide the answer is not “something unknown”. The chemistry that builds the chain leaves a predictable set of by-products, each derived from the target sequence, and the purity figure is the top line of that profile rather than a measure of cleanliness.

Solid phase synthesis in outline

The chain is built on an insoluble resin bead, one residue at a time, from the C terminal end towards the N terminal end. Each cycle repeats the same four operations.

  1. Deprotect. The temporary protecting group on the N terminus of the growing chain is removed so that the amine is free to react.
  2. Wash. Reagents and by-products are flushed away. The chain stays behind because it is anchored to the bead.
  3. Couple. The next amino acid, activated at its carboxyl group and still protected on its own N terminus and on any reactive side chain, forms the new peptide bond.
  4. Wash again, then repeat.

When the sequence is complete the chain is cleaved from the resin with a strong acid mixture, which in the same step strips the side chain protecting groups. The crude product is precipitated, usually into cold ether, collected, redissolved, purified by preparative reversed phase chromatography, and lyophilised.

Each operation has a yield slightly below perfect, and each imperfection leaves a specific, identifiable species behind.

Deletion and truncated sequences

If a coupling step does not go to completion, a fraction of the chains on the resin still carry a free amine at the point when the next cycle begins. What happens next splits them into two families.

A deletion sequence arises when that free amine survives the wash and reacts in the following cycle. The chain continues growing, but it is missing one internal residue. The product is nearly the same length and polarity as the target, which is why deletions sit closest to the main peak in a chromatogram and are the hardest to remove by purification.

A truncated chain arises when the unreacted amine is deliberately capped, usually by acetylation, so it cannot react again. The chain stops at that length. Truncations differ from the target by more residues and are easier to separate, both during purification and on an analytical trace.

Capping is a choice between the two families. It converts a hard to remove deletion into an easier to remove truncation.

Protecting groups that did not come off

Side chain protecting groups are removed by the acid cleavage mixture, not by the synthesis cycles, and some are more stubborn than others. Arginine, cysteine, histidine, tryptophan and the acidic and hydroxyl bearing residues each carry their own group with its own removal behaviour.

A chain that keeps one of these is a distinct substance with a fixed extra mass and extra hydrophobicity. It shows up twice: as a later eluting peak on the chromatogram, because the retained group is non-polar, and as a fixed mass offset in the mass spectrum. The two observations identify it between them, which is why identity and purity data are read together.

Incomplete removal of the temporary N terminal group works differently. It adds no mass to the final product, but it blocks the next coupling, so it feeds back into the deletion and truncation families above.

Side reactions on sensitive residues

Certain residues react in ways the cycle did not intend. Methionine, tryptophan and cysteine are prone to oxidation, which adds oxygen without changing the sequence. Aspartic acid followed by glycine is a well known site for ring closure to an aspartimide, which then opens again to give a rearranged chain of identical mass. Histidine and cysteine are the residues most often associated with loss of stereochemical purity during activation.

These produce species of the same or nearly the same mass as the target, so they are found chromatographically rather than by mass alone.

What is in the vial besides peptide

Three contributions add mass to the powder but are not represented in the HPLC purity figure.

Component Where it comes from How it is measured
Counterion The acid used in cleavage and in the purification mobile phase Its own assay, not HPLC area percent
Water Hygroscopic lyophilised powder, residual solvent Karl Fischer titration
Residual scavengers and solvents Cleavage cocktail additives, precipitation solvent Residual solvent testing

Scavengers are added to the cleavage mixture on purpose. They intercept the reactive fragments released when protecting groups come off, which would otherwise attack tryptophan, methionine and other sensitive residues. Precipitation and purification remove them, but a small residue is a normal finding rather than an anomaly.

Why the remaining percent is a profile

Random contamination has no structure. You cannot predict it, you cannot name it, and the only response is to clean up. Synthesis by-products are the opposite on every count. They are predictable from the sequence: a chain with three arginines has three chances of incomplete deprotection, and one containing Asp followed by Gly has a known weak point. They are chemically related to the target, so they behave similarly in chromatography, and that similarity is the diagnostic. And they are controlled by purification rather than by exclusion.

This is what makes a chromatogram worth reading rather than merely reporting. A batch whose minor peaks cluster tightly around the main peak and a batch with the same figure spread across distant peaks are different materials. The documentation accompanying each batch is described under quality, and the terms used here sit in the glossary.